Cargando…
FRI651 Usage Of Modern Sulphonylureas And Metformin Fixed Dose Combination (fdc) In Type 2 Diabetes Mellitus (t2dm) Patients With Established Complications
Disclosure: A. M: None. D. Prasad: None. D. Birla: None. L. Nagendra: None. B. Bansal: None. S. Shaikh: None. Aim: To evaluate the usage of sulphonylureas (SUs) and metformin fixed dose combinations (FDC) in type 2 diabetes mellitus (T2DM) patients with established complications Background: Patients...
Autores principales: | M, Aushili, Prasad, Dr Ashish, Nagendra, Lakshmi, Sinha, Binayak, Bansal, Beena, Shaikh, Shehla |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10555671/ http://dx.doi.org/10.1210/jendso/bvad114.870 |
Ejemplares similares
-
FRI649 ADMIRE: Assessing Dapagliflozin And Metformin As An Initial Regimen In Diabetes Mellitus For Enhanced Glucose Control
por: Phadke, Dr Uday, et al.
Publicado: (2023) -
THU249 Use Of The Pittsburgh Sleep Quality Index In People WithT2DM: Initial Results Of The Diabetes Sleep Assessment (DSA) Study
por: Shaikh, Shehla, et al.
Publicado: (2023) -
FRI636 Sleep Architecture In Diabetic Patients With Sleep Apnea On Metformin
por: Varma, Madhu, et al.
Publicado: (2023) -
FRI655 Impact Of Digital Twin Intervention On Visceral Fat And Glycemic Control In T2dm With Different Levels Of Visceral Fat
por: Rameshchandra Joshi, Shashank, et al.
Publicado: (2023) -
FRI652 Type 2 Diabetes Management: More GLP1 Agonists And Less Metformin?
por: Lopez Maldonado, Francisco J, et al.
Publicado: (2023)